Weatherald J - Search Results

1

Chronic Fatigue and Postexertional Malaise in People Living With Long COVID: An Observational Study.

Twomey R, DeMars J, Franklin K, Culos-Reed SN, Weatherald J, Wrightson JG. Twomey R, et al. Among authors: weatherald j. Phys Ther. 2022 Apr 1;102(4):pzac005. doi: 10.1093/ptj/pzac005. Phys Ther. 2022. PMID: 35079817 Free PMC article.

2

Patients' perceptions on clinical trials outcomes in pulmonary arterial hypertension therapy.

Mai V, Gosselin C, Tremblay É, Rompré G, Lajoie AC, Weatherald J, Lega JC, Bonnet S, Provencher S. Mai V, et al. Among authors: weatherald j. Thorax. 2023 Jul;78(7):721-725. doi: 10.1136/thorax-2022-219490. Epub 2023 May 4. Thorax. 2023. PMID: 37142420

3

Win Statistics in Pulmonary Arterial Hypertension Clinical Trials.

Weatherald J, Moutchia J, Al-Naamani N, McClelland RL, Ventetuolo CE, Palevsky HI, Harhay MO, Kawut SM. Weatherald J, et al. Am J Respir Crit Care Med. 2023 Dec 1;208(11):1231-1234. doi: 10.1164/rccm.202305-0800LE. Am J Respir Crit Care Med. 2023. PMID: 37734029 Free PMC article. No abstract available.

4

Rebuttal From Drs Weatherald and Sitbon.

Weatherald J, Sitbon O. Weatherald J, et al. Chest. 2024 Mar;165(3):496-498. doi: 10.1016/j.chest.2023.10.002. Chest. 2024. PMID: 38461013 No abstract available.

5

The evolving landscape of pulmonary arterial hypertension clinical trials.

Weatherald J, Boucly A, Peters A, Montani D, Prasad K, Psotka MA, Zannad F, Gomberg-Maitland M, McLaughlin V, Simonneau G, Humbert M; Evolving Landscape of Pulmonary Arterial Hypertension and Redesigning Pulmonary Arterial Hypertension Clinical Trials Task Force of the 18th Global CardioVascular Clinical Trialists Forum. Weatherald J, et al. Lancet. 2022 Nov 26;400(10366):1884-1898. doi: 10.1016/S0140-6736(22)01601-4. Lancet. 2022. PMID: 36436527 Review.

6

PDE5 to keep them alive: The use of phosphodiesterase type-5 inhibitors in severe pulmonary hypertension associated with interstitial lung disease.

Weatherald J, Humbert M. Weatherald J, et al. Respirology. 2023 Mar;28(3):212-214. doi: 10.1111/resp.14399. Epub 2022 Nov 1. Respirology. 2023. PMID: 36318987 Free article. No abstract available.

7

Management of Pulmonary Arterial Hypertension.

Weatherald J, Varughese RA, Liu J, Humbert M. Weatherald J, et al. Semin Respir Crit Care Med. 2023 Dec;44(6):746-761. doi: 10.1055/s-0043-1770118. Epub 2023 Jun 27. Semin Respir Crit Care Med. 2023. PMID: 37369218

8

Pulmonary Hypertension in Connective Tissue Diseases Other than Systemic Sclerosis.

Budhram B, Weatherald J, Humbert M. Budhram B, et al. Among authors: weatherald j. Semin Respir Crit Care Med. 2024 Jun;45(3):419-434. doi: 10.1055/s-0044-1782217. Epub 2024 Mar 18. Semin Respir Crit Care Med. 2024. PMID: 38499196 Review.

9

Illuminating the Importance of Pulmonary Arterial Compliance in Pulmonary Hypertension.

Weatherald J, Zanini U, Humbert M. Weatherald J, et al. Am J Respir Crit Care Med. 2023 Aug 1;208(3):231-233. doi: 10.1164/rccm.202306-0990ED. Am J Respir Crit Care Med. 2023. PMID: 37348119 Free PMC article. No abstract available.

10

POINT: Should the Use of Upfront Triple Combination Therapy Be Standard of Care in Pulmonary Arterial Hypertension? Yes.

Weatherald J, Sitbon O. Weatherald J, et al. Chest. 2024 Mar;165(3):492-494. doi: 10.1016/j.chest.2023.10.001. Chest. 2024. PMID: 38461011 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

130 results

Search Page

Filters